drugset / Trial / NCT03464526
A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effectiveness of three doses of orvepitant, taken once a day, in the treatment of pruritus associated with atopic dermatitis.
Timeline
- Start
- 2018-05
- Primary completion
- 2019-06
- Completion
- 2019-10
Outcome
Outcome not reported
Stopped (Business): “Strategic decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Orvepitant | Small molecule | 10 mg | Oral |
| Comparator | Orvepitant | Small molecule | 20 mg | Oral |
| Comparator | Orvepitant | Small molecule | 30 mg | Oral |